(Q40328350)

19 September 2017

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma (English)

1 reference

19 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

9

Yutaka Ueda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

14

Masako Shida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

18

Sosuke Adachi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

31

Lynda D Roman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

17

Hiroko Machida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

12

Kosei Hasegawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

19

Yuji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

23

Masato Nishimura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

10

Tadao Takano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

13

Tsukasa Baba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

11

Erin A Blake

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

Malcolm S Ross

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

27

Tanja Pejovic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

16

Takuhei Yokoyama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

2

Kohei Omatsu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

5

Mayu Yunokawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

Merieme M Klobocista

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

20

Keita Iwasaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

22

Shiori Yanai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

24

Tadayoshi Nagano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

25

Munetaka Takekuma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

29

Frederick R Ueland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

30

Joseph L Kelley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

26

Satoshi Takeuchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Marian S Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dwight D Im

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Stephen H Bush

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Shinya Satoh

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Takahito M Miyake

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mian Mk Shahzad

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

16 February 2017

1 reference

19 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

78-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28215838%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

cites work

Uterine sarcomas 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Diagnosis and treatment of sarcoma of the uterus. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Pathology of mixed Müllerian tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Uterine carcinosarcoma: A review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Patterns of recurrence in malignant mixed müllerian tumor of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Prognostic features of surgical stage I uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

A simulation study of the number of events per variable in logistic regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Overadjustment bias and unnecessary adjustment in epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Role of radiotherapy treatment of uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Radiotherapy for rhabdomyosarcoma: indications and outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.001

Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: clinicoimmunohistochemical and histogenetic characteristics

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28215838

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28215838

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28215838